A semiquantitative PCR method (SQ-PCR) to measure Epstein-Barr virus (EBV) load: Its application in transplant patients

Journal of Clinical Virology

Volumn 28, Issue 3, 2003, Pages 323-330

  Fellner, María Dolores ^a,c   Durand, Karina ^a   Correa, Mariel ^a   Bes, David ^b   Alonio, Lidia V ^a   Teyssié, Angélica R ^a   Picconi, María Alejandra ^a  

^a Inst Nac Enferm I   (Argentina)

^b HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^c NONE   (Argentina)

Author keywords

DNA quantitation; Epstein Barr virus; PTLD; Transplant patients; Viral load

Indexed keywords

VIRUS DNA;

ANALYTIC METHOD; ARTICLE; BLOOD CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; DILUTION; DISEASE ASSOCIATION; DNA DETERMINATION; EPSTEIN BARR VIRUS; EVALUATION; FOLLOW UP; HUMAN; HUMAN CELL; LYMPHOPROLIFERATIVE DISEASE; MEASUREMENT; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECIPIENT; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; SURGICAL PATIENT; SYMPTOMATOLOGY; VIRUS CARRIER; VIRUS DETECTION; VIRUS LOAD;

EID: 0141428847     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(03)00077-5     Document Type: Article

References (36)

1. Adams A. Replication of latent Epstein Barr virus genomes in Raji cells. J. Virol. 61:1987;1743-1746.
2. Allen U., Hebert D., Petric M., Tellier R., Tran D., Superina R., Stephens D., West L., Wasfy S., Nelson S. Utility of semiquantitative polymerase chain reaction for Epstein Barr virus to measure virus load in pediatric organ transplant recipients with and without posttransplant lymphoproliferative disease. Clin. Infect. Dis. 33:2001;145-150.
3. Babcock G.J., Decker L.L., Volk M., Thorley Lawson D.A. EBV persistence in memory B cells in vivo. Immunity. 9:1998;395-404.
4. Baldanti F., Grossi P., Furione M., Simoncini L., Sarasini A., Comoli P., Maccario R., Fiocchi R., Gerna G. High levels of Epstein Barr Virus DNA in blood of solid organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders. J. Clin. Microbiol. 38:2000;613-619.
5. Cockfield S.M. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transplant. Infect. Dis. 3:2001;70-78.
6. Faulkner G.C., Krajewski A.S., Crawford D.H. The ins and outs of EBV infection. Trends. Microbiol. 8:2000;185-189.
7. Green M, Reyes J, Jabbour N, Yunis E, Putnap, Todo S, Rowe D. Use of Quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children, Transplant Proc (1996); 28:2759-2760.
8. Green M., Reyes J., Webber S., Michaels M.G., Rowe D. The role of viral load in the diagnosis, management, and possible prevention of Epstein Barr virus-associated posttransplant lymphoproliferative disease following solid organ transplantation. Curr. Opin. Organ. Transplant. 4:1999;292-296.
9. Green M., Reyes J., Webber S., Rowe D. The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr infection and post-transplant lymphoproliferative disease following solid organ transplantation. Transplant. Infect. Dis. 3:2001;97-103.
10. Harvard Medical School. Preparation and analysis of DNA. In: Ausubel FM, Brent R, Kingston R, Moore D, Seidman J, Smith J, Struhl K, editors. Short Protocols in Molecular Biology, 2nd ed. Greene Publishing Associates and John Wiley & Sons, USA. 1992;2, pp. 4-5.
11. Jabs W.J., Hennig H., Kittel M., Pethig K., Smets F., Bucsky P., Kirchner H., Wagner H.J. Normalized quantification by real time PCR of Epstein-Barr Virus load in patients at risk for posttransplant lymphoproliferative disorders. J. Clin. Microbiol. 39:2001;564-569.
12. Jekel J.F., Elmore J.G., Katz D.L. Understanding and reducing errors in clinical medicine. Epidemiology Biostatistics and Preventive Medicine. 1996;86-97 WB Saunders company, USA.
13. Kenagy D.N., Schlesinger Y., Weck K., Ritter J.H., Gaudrealt-Keener M.M., Storch G.A. Epstein Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease. Transplantation. 60:1995;547-554.
14. Khan G., Miyashita E.M., Yang B., Babcock G.J., Thorley-Lawson D.A. Is EBV persistence in vivo a model for B cell homeostasis? Immunity. 5:1996;173-179.
15. Khanna R., Burrows S.R., Moss D.J. Immune regulation in Epstein-Barr virus-associated diseases. Microbiol. Rev. 59:1995;387-405.
16. Kieff E. Epstein-Barr virus and its replication. Fields B.N., Knipe D.M., Howley P.M. 3rd ed. Virology. 2:1996;2343-2396 Lippincott-Raven, Philadelphia.
17. Kimura H., Morita M., Yabuta Y., Kuzushima K., Kato K., Kojima S., Matsuyama T., Morishima T. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J. Clin. Microbiol. 37:1999;132-136.
18. Meerbach A., Gruhn B., Egerer R., Reischl U., Zintl F., Wutzler P. Semiquantitative PCR analysis of Epstein Barr virus DNA in clinical samples of patients with EBV-associated diseases. J. Med. Virol. 65:2001;348-357.
19. Miyashita E.M., Yang B., Babcok G.J., Thorley-Lawson D.A. Identification of the site of Epstein Barr virus persistence in vivo as resting B cell. J. Virol. 71:1997;4882-4891.
20. Nadal D., Blasius M., Niggli F.K., Meier G., Berger C. Epstein-Barr Virus (EBV) DNA levels in palatine tonsils and autologous serum from EBV carriers. J. Med. Virol. 67:2002;54-58.
21. Nalesnik M.A. The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach. Transplant. Infect. Dis. 3:2001;88-96.
22. Niesters H.G.M., van Esser J., Fries E., Wolthers K.C., Cornelissen J., Osterhaus A. Development of a real time quantitative assay for detection of Epstein-Barr Virus. J. Clin. Microbiol. 38:2000;712-715.
23. Paya CV, Fung JJ, Nalesnik MA, Kieff E, Green M, Gores G, Habermann TM, Wiesner RH, Swinnen LJ, Woodle ES, Bromberg JS for the ASTS/ASTP EBV-PTLD Task Force and the Mayo Clinic organized International Concensus Development Meeting on Epstein Barr Virus-Induced posttransplant Lymphoproliferative Disorders (PTLD). Epstein Barr Virus-induced posttransplant lymphoproliferative disorders, Transplantation (1999);68:1517-1525.
24. Qu L., Green M., Webber S., Reyes J., Ellis D., Rowe D. Epstein Barr Virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads. J. Infect. Dis. 182:2000;1013-1021.
25. Rickinson A.B., Kieff E. Epstein Barr Virus. Fields B.N., Knipe D.M., Howley P.M. 3th ed. Virology. 2:1996;2397-2446 Lippincott-Raven, Philadelphia.
26. Riddler S.A., Breinig M.C., McKnight L.C. Increased levels of circulating Epstein Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood. 84:1994;972-984.
27. Rose C., Green M., Webber S., Ellis D., Reyes J., Rowe D. Pediatric solid-organ transplant recipients carry chronic loads of Epstein-Barr exclusively in the immunoglobulin D-negative B-cell compartment. J. Clin. Microbiol. 39:2001;1407-1415.
28. Rowe D.T., Qu L., Reyes J., Jabbour N., Yunis E., Putnam P., Todo S., Green M. Use of quantitative competitive PCR to measure Epstein Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J. Clin. Microbiol. 35:1997;1612-1615.
29. Rowe D.T., Webber S., Schauer E.M., Reyes J., Green M. Epstein Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease. Transplant. Infect. Dis. 3:2001;79-87.
30. Saito I, Servenius B, Compton T, Fox R. Detection of Epstein-Barr Virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's Syndrome, J Exp Med (1989);169:2191-2198.
31. Stevens S., Vervoort M., van den Brule A., Meenhorst P.T., Meijer C., Middeldorp J.M. Monitoring of Epstein Barr Virus DNA load in peripheral blood by quantitative competitive PCR. J. Clin. Microbiol. 37:1999;2852-2857.
32. Stevens S.J., Middeldorp J.M. Nucleic acid-based diagnostic approaches in EBV-associated disease. Epstein Barr Virus Rep. 8:2001;31-39.
33. Sykes P.J., Neoh S.H., Brisco M.J., Hughes E., Condon J., Morley A.A. Quantitation of targets for PCR by use of limiting dilution. Biotechniques. 13:1992;444-449.
34. Thorley Lawson D.A. EBV: schizophrenic but not dysfunctional. Epstein Barr Virus Rep. 6:1999;8-163.
35. Wagner H.J., Bein G., Bitsch A., Kirchner H.J. Detection and quantitation of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction. J. Clin. Microbiol. 30:1992;2826-2829.
36. Yang J., Tao Q., Flinn I.W., Murray P.G., Post L.E., Ma H., Piantadosi S., Cagliuri M.A., Ambinder R.F. Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response. Blood. 96:2000;4055-4064.